Pr Christophe Massard

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials. (16 mai 2025)
• Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry. (1 avr. 2025)
• Innovative, early-phase clinical trials of drug-radiotherapy combinations. (1 avr. 2025)
• Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results. (17 mars 2025)
• Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. (10 mars 2025)